Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02027571 · ClinicalTrials.gov registry record · NA
Pathobiology and Reversibility of Prediabetes in a Biracial Cohort
A NA study, sponsored by University of Tennessee.
- Completed
- Registry status
- NA
- Development phase
- 223
- Enrollment target
NCT02027571: Completed NA study, sponsored by University of Tennessee.
NCT02027571 is a NA study that has completed, run by University of Tennessee. The registered enrollment target is 223 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02027571, a NA study, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- NA
- Development phase
- 223 participants
- Enrollment target
Study Summary
The reasons for the epidemics of diabetes and prediabetes, and why individuals from certain populations suffer at higher rates are not well known. In the Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC) study, nearly 400 African Americans and Caucasians whose parents have type 2 diabetes will undergo repeated testing to determine what factors lead to the occurrence of prediabetes, and whether race still plays a major role in a setting where everyone being studied has one or both parents with diabetes. The PROP-ABC Study also will test the hypothesis that the ability of intensive lifestyle intervention to reverse prediabetes and return people's metabolism back to normal is dependent on how long people have had prediabetes.
Primary Outcome
The primary outcome measure is restoration of normal glucose regulation (FPG \<100 mg/dl and 2hrPG \< 140 mg/dl).
Interventions
- BEHAVIORAL Intensive Lifestyle Intervention (ILI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2013-10 |
| Est. Completion | 2018-10 |
| Phase | NA |
What the finished NCT02027571 record still lists
NCT02027571 is an interventional study that assigns participants to a tested intervention. The registered 223 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 1 intervention - of which Intensive Lifestyle Intervention (ILI) is the first listed.
NCT02027571 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02027571 about?
NCT02027571 is a clinical study titled "Pathobiology and Reversibility of Prediabetes in a Biracial Cohort". The reasons for the epidemics of diabetes and prediabetes, and why individuals from certain populations suffer at higher rates are not well known. In the Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC) study, nearly 400 African Americans and Caucasians whose parents hav...
What is the current status of trial NCT02027571?
This trial is currently completed. It is a NA study. The enrollment target is 223 participants. The study started on 2013-10. Estimated completion is 2018-10.
What interventions are being tested in trial NCT02027571?
The interventions under investigation include: Intensive Lifestyle Intervention (ILI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02027571?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02027571's enrollment target sits among peer trials
223 481st of 2000 higher than 1,520 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06640803 · 223 participants · NA
Sacramento Clinical High Risk for Psychosis Stepped-Care Program
- NCT07175285 · 223 participants
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- NCT07205718 · 223 participants · Phase 1
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
- NCT02706561 · 224 participants · NA
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia